This statistic shows the sales value of outpatient prescription drugs for benign prostatic hyperplasia (BPH) in South Korea in 2016, by age group. In 2016, the BPH medication sales for patients aged between 70 and 79 years amounted to over 92 billion South Korean won.
Sales value of outpatient prescription drugs for benign prostatic hyperplasia (BPH) in South Korea in 2016, by age group
(in billion South Korean won)
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
KHIDI. (February 6, 2018). Sales value of outpatient prescription drugs for benign prostatic hyperplasia (BPH) in South Korea in 2016, by age group (in billion South Korean won) [Graph]. In Statista. Retrieved December 22, 2024, from https://www.statista.com/statistics/863824/south-korea-prostatic-hyperplasia-outpatient-prescription-drug-sales-by-age-group/
KHIDI. "Sales value of outpatient prescription drugs for benign prostatic hyperplasia (BPH) in South Korea in 2016, by age group (in billion South Korean won)." Chart. February 6, 2018. Statista. Accessed December 22, 2024. https://www.statista.com/statistics/863824/south-korea-prostatic-hyperplasia-outpatient-prescription-drug-sales-by-age-group/
KHIDI. (2018). Sales value of outpatient prescription drugs for benign prostatic hyperplasia (BPH) in South Korea in 2016, by age group (in billion South Korean won). Statista. Statista Inc.. Accessed: December 22, 2024. https://www.statista.com/statistics/863824/south-korea-prostatic-hyperplasia-outpatient-prescription-drug-sales-by-age-group/
KHIDI. "Sales Value of Outpatient Prescription Drugs for Benign Prostatic Hyperplasia (Bph) in South Korea in 2016, by Age Group (in Billion South Korean Won)." Statista, Statista Inc., 6 Feb 2018, https://www.statista.com/statistics/863824/south-korea-prostatic-hyperplasia-outpatient-prescription-drug-sales-by-age-group/
KHIDI, Sales value of outpatient prescription drugs for benign prostatic hyperplasia (BPH) in South Korea in 2016, by age group (in billion South Korean won) Statista, https://www.statista.com/statistics/863824/south-korea-prostatic-hyperplasia-outpatient-prescription-drug-sales-by-age-group/ (last visited December 22, 2024)
Sales value of outpatient prescription drugs for benign prostatic hyperplasia (BPH) in South Korea in 2016, by age group (in billion South Korean won) [Graph], KHIDI, February 6, 2018. [Online]. Available: https://www.statista.com/statistics/863824/south-korea-prostatic-hyperplasia-outpatient-prescription-drug-sales-by-age-group/
